Skip to content

H.R. 3029 · 119th Congress (2025–2027)

To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.

This bill explicitly requires the National Institute of Standards and Technology (NIST) to support the development of best practices and technical standards for nucleic acid synthesis.

Nucleic acids, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), carry genetic information within cells. Nucleic acid synthesis is the process of designing and creating custom nucleic acids; it is used in the development of medications and agricultural products. However, this technology also poses a risk of misuse (e.g., the intentional or unintentional creation of dangerous biological agents).

The bill requires NIST to carry out measurement research to support the development and improvement of biosecurity best practices and technical standards related to nucleic acid synthesis. This effort must address specified topics including nucleic acid synthesis screening, operational security, and conformity assessment. (A 2023 executive order titled Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence directed NIST to develop and refine similar specifications and best practices for use by synthetic nucleic acid providers. NIST's work on this topic is ongoing.)

In carrying out this effort, NIST must convene stakeholders to develop and periodically update consensus priorities and best practices for synthetic nucleic acid screening mechanisms. Within a specified period, NIST must submit a summary of the stakeholder group’s findings to Congress.

NIST must also take steps to advance risk management best practices and technical standards for engineering biology and biomanufacturing, including with respect to risks associated with the use of artificial intelligence.

Passed House

Latest actionReferred to committee

This bill’s path

448 days after it was introduced

This is H.R. 3029’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced15 months

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Andrea Salinas (D-OR-6)
Cosponsors
3 cosponsors

1 original · 2 later

  1. Rep. Richard McCormick (R-GA-7)· Original · Apr 28, 2025
  2. Rep. Sarah McBride (D-DE)· Later · Apr 29, 2025
  3. Rep. Josh Riley (D-NY-19)· Later · Apr 30, 2025
Policy area
Science, Technology, Communications
Subjects
  • Biological and life sciences
  • Cell biology and embryology
  • Research and development

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. ▸ 4 committee actions · Apr 28, 2025 – Jul 16, 2026
    1. Referred to committee

      Referred to the House Committee on Science, Space, and Technology.

      Sources
    2. Markup session held

      Committee Consideration and Mark-up Session Held

      Sources
    3. Ordered reported

      Ordered to be Reported by Voice Vote.

      Sources
    4. Reported by committee

      Reported by the Committee on Science, Space, and Technology. H. Rept. 119-751.

      Sources
  3. Passed House

    Congressional Record H4666

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

    The House passed the bill as amended.

    Document: Engrossed in House

    Sources
  4. Latest

    Referred to committee

    Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

    Sources

Committees

  1. HouseScience, Space, and TechnologyReferred Apr 28, 2025 · Markup Apr 29, 2025 · Reported Jul 16, 2026H. Rept. 119-751
    1. Apr 29, 2025 · Markup

    1. H. Rept. 119-751 · Jul 16, 2026 · Nucleic Acid Standards for Biosecurity Act
  2. SenateCommerce, Science, and TransportationReferred Jul 21, 2026

Floor record

i

Explicit consideration evidence: the measure’s bill-status citation matched a GovInfo title, headline, or first paragraph. Incidental mentions are not listed.

  1. Jul 20, 2026 · House · Considered under suspension of the rulesCongressional Record H4666–H4667

    Nucleic Acid Standards for Biosecurity Act

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Reported in House
Engrossed in House
Referred in Senate
Titles (2)
  1. To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.

    Display title, Official title · Engrossed in House, Introduced in House

  2. Nucleic Acid Standards for Biosecurity Act

    Short title · Introduced in House